Results 11 to 20 of about 26,190 (208)
PLoS ONE, 2019 This study aimed to identify the trends in the incidence of thymic cancer, i.e., thymoma, thymic carcinoma, and thymic neuroendocrine tumor, in the United States.
Chun-Hsiang Hsu +5 more
doaj +4 more sources
Applied Radiology, 2016 Thymic carcinomas are a heterogeneous group of aggressive, invasive epithelial malignancies. Their incidence is rare, occurring predominantly in middle-aged men. Here we present the typical imaging findings of a thymic carcinoma.
Torres, Felipe Soares +5 more
core +9 more sources
Diagnosis of Thymic Clear Cell Carcinoma by Cytology [PDF]
Case Reports in Pathology, 2013 Clear cell carcinoma of the thymus is a rare tumor. Few cases of clear-cell carcinoma of thymus have been documented (Truong et al., 1990 and Wolfe III et al., 1983).
Seema A. Lale +2 more
doaj +2 more sources
Thymic Carcinoma Presenting as Disseminated Intravascular Coagulation [PDF]
Case Reports in Oncological Medicine, 2014 Thymomas and thymic carcinomas are rare tumors, which originate from the epithelial cells of the thymus. We present a case of thymic carcinoma, which presented with DIC as an initial manifestation.
Mamatha Siricilla +2 more
doaj +2 more sources
Frontiers in Oncology, 2022 The diagnosis of thymic carcinoma may pose significant problems not necessarily in the histopathological diagnosis but rather in assigning the thymus as specific origin.
Doaa Alqaidy, Cesar A. Moran
doaj +3 more sources
Molecular predictors of response to pembrolizumab in thymic carcinoma
Cell Reports Medicine, 2021 Summary: Thymic carcinoma is rare and has a poorer prognosis than thymomas. The treatment options are limited after failure of platinum-based chemotherapy.
Yongfeng He +4 more
doaj +3 more sources
Elevated serum CYFRA 21‐1 level as a diagnostic marker for thymic carcinoma
Thoracic Cancer, 2021 Background No useful tumor markers have been identified for the diagnosis of thymic carcinomas. Serum cytokeratin 19 fragment, measured using the CYFRA 21‐1 immunoassay, is used as a tumor marker for squamous cell carcinomas in various malignant tumors ...
Haruhiko Shiiya +10 more
doaj +2 more sources
LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
Journal of Pharmacological Sciences, 2016 L-type amino acid transporter 1 (LAT1, SLC7A5) incorporates essential amino acids into cells. Recent studies have shown that LAT1 is a predominant transporter in various human cancers.
Keitaro Hayashi +8 more
doaj +2 more sources
Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma
Journal of Cardiothoracic SurgeryBackground The purpose of this study was to evaluate the clinicopathological characteristics of patients who underwent surgical resection for thymic neuroendocrine tumors (TNET) or thymic carcinoma. Methods In this study, we retrospectively evaluated the
Kensuke Midorikawa +6 more
doaj +2 more sources
Hepatoid thymic carcinoma: a case report of a rare subtype of thymic carcinoma [PDF]
Journal of Pathology and Translational Medicine, 2021 Hepatoid thymic carcinoma is an extremely rare subtype of primary thymus tumor resembling “pure” hepatoid adenocarcinomas with hepatocyte paraffin 1 (Hep-Par-1) expression. A 53-year-old man presented with voice change and a neck mass.
강효정 +5 more
core +4 more sources